Steven Simoens
Steven Simoens publishes mostly in Economics and Econometrics, Immunology and General Health Professions, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Biosimilars and Bioanalytical Methods.
- World rank
- #246,690 of 7,710,434 ranked researchers
- Rank in Belgium
- #1,881 of 67,186
- Works
- 692
- Citations
- 17k
- Citations per work
- 23.9
What does Steven Simoens research?
Steven Simoens's work is mostly in Economics, Econometrics and Finance (38%), Medicine (12%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences26237.8%
- Everything else25737.2%
- Health Sciences12718.3%
- Medicine8612.4%
- Health Professions415.9%
- Life Sciences466.7%
- 1Economics and Econometrics38% of their works
- 2Immunology7% of their works
- 3General Health Professions6% of their works
- 4Public Health, Environmental and Occupational Health5% of their works
- 5Pediatrics, Perinatology and Child Health4% of their works
- 6Geriatrics and Gerontology3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Pharmaceutical studies and practices
- Pharmaceutical Practices and Patient Outcomes
- Economic and Financial Impacts of Cancer
- Intellectual Property and Patents
- Healthcare cost, quality, practices
Which keywords describe Steven Simoens's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Drug Development Costs, Generic Drugs, Biosimilars, Immunogenicity, Off-Label Drug Use and Pediatric Pharmacokinetics.
- Low-Value Care
- Patent Analysis
- Financial Toxicity
- Polypharmacy
- Pediatric Pharmacokinetics
- Immunogenicity
- Generic Drugs
- Quality of Life
- Cost-effectiveness Analysis
- Drug Development Costs
- Biosimilars
- Off-Label Drug Use
- Inappropriate Medication Use
- Cost of Care
- Intellectual Property Rights
- Choosing Wisely
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost-effectiveness Analysis3191 topic
- Quality of Life3191 topic
- Drug Development Costs2951 topic
- Generic Drugs2951 topic
- Biosimilars1081 topic
- Immunogenicity1081 topic
- Off-Label Drug Use721 topic
- Pediatric Pharmacokinetics721 topic
- Inappropriate Medication Use531 topic
- Polypharmacy531 topic
- Cost of Care361 topic
- Financial Toxicity361 topic
- Intellectual Property Rights291 topic
- Patent Analysis291 topic
- Choosing Wisely271 topic
- Low-Value Care271 topic
Where does Steven Simoens work?
Steven Simoens's main affiliation in the publication record is KU Leuven, Belgium.
How many publications and citations does Steven Simoens have?
OpenAlex counts 692 works and 16,532 citations for Steven Simoens, an h-index of 65, ranking #246,690 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Steven Simoens. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.